{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:00:24Z","timestamp":1790827224037,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf03192290","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T13:19:31Z","timestamp":1288703971000},"page":"61-71","source":"Crossref","is-referenced-by-count":13,"title":["Metabolism of levomepromazine in man"],"prefix":"10.1007","volume":"20","author":[{"given":"P. -A.","family":"Hals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03192290_CR1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00004714-199312000-00016","volume":"13","author":"S.B. Lippmann","year":"1993","unstructured":"Lippmann S.B. (1993): Can I use Levoprome (methotrimeprazine) in psychiatry? J. Clin. Psychopharmacol., 13, 456.","journal-title":"J. Clin. Psychopharmacol."},{"key":"BF03192290_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0090-9556(25)07838-9","volume":"10","author":"H. Johnsen","year":"1982","unstructured":"Johnsen H., Dahl S.G. (1982): Identification of O-demethylated and ring-hydroxylated metabolites of methotrimeprazine (levomepromazine) in man. Drug Metab. Dispos., 10, 63\u201367.","journal-title":"Drug Metab. Dispos."},{"key":"BF03192290_CR3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-3565(25)32494-8","volume":"217","author":"D.B. Bylund","year":"1981","unstructured":"Bylund D.B. (1981): Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. J. Pharmacol. Exp. Ther., 217, 81\u201386.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03192290_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00432672","volume":"74","author":"D.G. Dahl","year":"1981","unstructured":"Dahl D.G., Hall H. (1981): Binding affinity of levomepromazine and two of its major metabolites to central dopamine and \u03b1-adrenergic receptors in the rat. Psychopharmacology, 74, 101\u2013104.","journal-title":"Psychopharmacology"},{"key":"BF03192290_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(86)90793-4","volume":"125","author":"P.-A. Hals","year":"1986","unstructured":"Hals P.-A., Hall H., Dahl S.G. (1986): Phenothiazine drug metabolites: dopamine D2 receptor, \u03b11- and \u03b12-adrenoceptor binding. Eur. J. Pharmacol., 125, 373\u2013381.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03192290_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0024-3205(88)90519-X","volume":"43","author":"P.-A. Hals","year":"1988","unstructured":"Hals P.-A., Hall H., Dahl S.G. (1988): Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites. Life Sci., 43, 405\u2013412.","journal-title":"Life Sci."},{"key":"BF03192290_CR7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0024-3205(90)90088-9","volume":"46","author":"J.Z. Nowak","year":"1990","unstructured":"Nowak J.Z., Arbilla S., Dahl S.G., Langer S.Z. (1990): Antagonism of presynaptic dopamine receptors by phenothiazine drug metabolites. Life Sci., 46, 443\u2013451.","journal-title":"Life Sci."},{"key":"BF03192290_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(76)90031-5","volume":"37","author":"S.G. Dahl","year":"1976","unstructured":"Dahl S.G., Refsum H. (1976): Effects of levomepromazine, chlopromazine and their sulfoxides on isolated rat atria. Eur. J. Pharmacol., 37, 241\u2013248.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03192290_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(76)90059-5","volume":"40","author":"M. Passwal","year":"1976","unstructured":"Passwal M., Dahl S.G., Refsum H. (1976): Anticholinergic and cardiodepressive effects of levomepromazine and two of its metabolites on isolated rat atria. Eur. J. Pharmacol., 40, 249\u2013254.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03192290_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF00215481","volume":"92","author":"E. Morel","year":"1987","unstructured":"Morel E., Lloyd K.G., Dahl S.G. (1987): Anti-apomorphine effects of phenothiazine drug metabolites. Psychopharmacology, 92, 68\u201372.","journal-title":"Psychopharmacology"},{"key":"BF03192290_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0773.1994.tb00357.x","volume":"75","author":"P.-A. Hals","year":"1994","unstructured":"Hals P.-A., Dahl S.G. (1994): Effect of levomepromazine and metabolites on debrisoquine hydroxylation in the rat. Pharmacol. Toxicol., 75, 255\u2013260.","journal-title":"Pharmacol. Toxicol."},{"key":"BF03192290_CR12","first-page":"89","volume":"11","author":"D.S. Davies","year":"1981","unstructured":"Davies D.S., Kahn G.C., Murray S., Brodie M.J., Boobis A.R. (1981): Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver. Biochem. Pharmacol., 11, 89\u201391.","journal-title":"Biochem. Pharmacol."},{"key":"BF03192290_CR13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00007691-199011000-00011","volume":"12","author":"T. Loennechen","year":"1990","unstructured":"Loennechen T., Andersen A., Hals P.-A., Dahl S.G. (1990): High-performance liquid chromatographic determination of levomepromazine (methotrimeprazine) and its main metabolites in serum and urine. Ther. Drug Monitor, 12, 574\u2013581.","journal-title":"Ther. Drug Monitor"},{"key":"BF03192290_CR14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.2042-7158.1981.tb13767.x","volume":"33","author":"D. Sharples","year":"1981","unstructured":"Sharples D. (1981): Photodecomposition of some substituted phenothiazines. J. Pharm. Pharmacol., 33, 242\u2013243.","journal-title":"J. Pharm. Pharmacol."},{"key":"BF03192290_CR15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jps.2600660214","volume":"66","author":"S.G. Dahl","year":"1977","unstructured":"Dahl S.G., Garle M. (1977): Identification of nonpolar methotrimeprazine metabolites in plasma and urine by GLC-mass spectrometry. J. Pharm. Sci., 66, 190\u2013193.","journal-title":"J. Pharm. Sci."},{"key":"BF03192290_CR16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/bms.1200091207","volume":"9","author":"S.G. Dahl","year":"1982","unstructured":"Dahl S.G., Johnsen H., Lee C.R. (1982): Gas chromatographic mass spectrometric identification of O-demethylated and mono-hydroxylated metabolites of levomepromazine in blood from psychiatric patients by selected ion recording with high resolution. Biomed. Mass Spectrom., 9, 534\u2013538.","journal-title":"Biomed. Mass Spectrom."},{"key":"BF03192290_CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jps.2600760710","volume":"76","author":"S.G. Dahl","year":"1987","unstructured":"Dahl S.G., Kauffmann E., Mompon B., Purcell T. (1987): Nuclear magnetic resonance analysis of methotrimeprazine (levomepromazine) hydroxylation in humans. J. Pharm. Sci., 76, 541\u2013544.","journal-title":"J. Pharm. Sci."},{"key":"BF03192290_CR18","first-page":"193","volume":"9","author":"P. Turano","year":"1968","unstructured":"Turano P., Canton C., Turner W.J., Merlis S. (1968): Chromatographic evidence for the existence of 8-hydroxy-chlorpromazine in urine. Agressologie, 9, 193\u2013194.","journal-title":"Agressologie"},{"key":"BF03192290_CR19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF00432774","volume":"77","author":"G. Alfredsson","year":"1982","unstructured":"Alfredsson G., Lindberg M., Sedvall G. (1982). The presence of 7-hydroxychlorpromazine in CSF of chlorpromazine-treated patients. Psychopharmacology, 77, 376\u2013378.","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03192290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03192290\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03192290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T13:28:36Z","timestamp":1740662916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03192290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF03192290"],"URL":"https:\/\/doi.org\/10.1007\/bf03192290","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}